TCWP’s Pfizer PFE Stock Holding History

TCWP’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,064	Closed	-$267K	–	91
2023 Q3	$267K	Sell	8,064 -3,719	-32%	-$132K	0.2%	84
2023 Q2	$432K	Sell	11,783 -379	-3%	-$14.8K	0.09%	118
2023 Q1	$496K	Sell	12,162 -3,649	-23%	-$158K	0.09%	139
2022 Q4	$810K	Sell	15,811 -1,828	-10%	-$87.6K	0.16%	115
2022 Q3	$771K	Sell	17,639 -12,889	-42%	-$626K	0.16%	113
2022 Q2	$1.6M	Sell	30,528 -456	-1%	-$23.2K	0.34%	80
2022 Q1	$1.6M	Sell	30,984 -5,460	-15%	-$283K	0.29%	85
2021 Q4	$2.15M	Buy	+36,444	New	+$1.81M	0.43%	69

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TCWP's PFE Position: Q4 2023 in Review

TCWP sold out of Pfizer (PFE) in Q4 2023, closing a stake of 8,064 shares — an estimated $267K sold.

TCWP first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $2.15M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

TCWP reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
TCWP sold 8,064 Pfizer shares in Q4 2023, an estimated $267K.
TCWP first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
TCWP's Pfizer position peaked at $2.15M in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on TCWP's 13F filing for Q4 2023, filed 14 Feb 2024.